January 30, 2024 12:22 PM EST
Pharma
Marketing

Mar­ket­ingRx roundup: Astel­las menopause drug led NFL TV spend­ing; A pod­cast's deep dive in­to Novo's his­to­ry

Beth Snyder Bulik

Senior Editor

Astel­las in­tro­duces menopause drug to NFL au­di­ence: Astel­las spent more mon­ey ad­ver­tis­ing its menopause drug Veozah than any oth­er new brand on reg­u­lar NFL …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

Am­gen names Stan­ford ge­neti­cist and biotech founder to CSO post

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

Cal­tech spin­out de­buts with AI-dri­ven 'mir­ror pep­tide' plat­form

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times